Norwegian Medicines Agency
E119701
The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Norwegian Medicines Agency canonical | 2 |
| Statens legemiddelverk | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T1046885 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Norwegian Medicines Agency Context triple: [Ministry of Health and Care Services (Norway), oversees, Norwegian Medicines Agency]
-
A.
Ministry of Health and Care Services (Norway)
The Ministry of Health and Care Services (Norway) is the national government ministry responsible for public health policy, healthcare services, and social care in Norway.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Norwegian Medicines Agency Target entity description: The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
-
A.
Ministry of Health and Care Services (Norway)
The Ministry of Health and Care Services (Norway) is the national government ministry responsible for public health policy, healthcare services, and social care in Norway.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
government agency
ⓘ
medicines regulatory authority ⓘ |
| abbreviation | NoMA ⓘ |
| aimsTo |
promote correct and effective use of medicines
ⓘ
protect patients from harmful medicines ⓘ |
| collects | adverse drug reaction reports ⓘ |
| cooperatesWith |
European Medicines Agency
ⓘ
World Health Organization ⓘ other national medicines agencies ⓘ |
| country | Norway ⓘ |
| hasRole |
competent authority for medicinal products in Norway
ⓘ
national regulatory authority for medicines in Norway ⓘ |
| headquartersLocation | Oslo ⓘ |
| issues |
guidelines for healthcare professionals on medicine use
ⓘ
safety warnings about medicines ⓘ |
| jurisdiction | Norway ⓘ |
| languageOfWorkOrName |
Norwegian language
ⓘ
surface form:
Norwegian
|
| nativeName |
Norwegian Medicines Agency
self-linksurface differs
ⓘ
surface form:
Statens legemiddelverk
|
| oversees |
biological medicinal products
ⓘ
biosimilar medicines ⓘ generic medicines ⓘ over-the-counter medicines ⓘ prescription medicines ⓘ |
| parentOrganization |
Ministry of Health and Care Services (Norway)
ⓘ
surface form:
Ministry of Health and Care Services of Norway
|
| participatesIn |
European medicines regulatory authorities
ⓘ
surface form:
European medicines regulatory network
|
| performs |
benefit-risk assessment of medicines
ⓘ
inspection of pharmaceutical manufacturers ⓘ inspection of wholesalers of medicines ⓘ |
| regulates |
medical devices
ⓘ
medicines ⓘ pharmaceutical products ⓘ veterinary medicines ⓘ |
| responsibleFor |
approval of medicines
ⓘ
control of pharmaceutical advertising ⓘ drug safety monitoring ⓘ efficacy of medicines ⓘ ensuring safe use of medicines ⓘ market authorisation of medicines ⓘ monitoring of medicines ⓘ pharmacovigilance ⓘ quality of medicines ⓘ regulation of clinical trials of medicines ⓘ safety of medicines ⓘ |
| sector |
healthcare
ⓘ
pharmaceutical regulation ⓘ |
| subjectOf | Norwegian pharmaceutical policy ⓘ |
| typeOfOrganization | public sector agency ⓘ |
| website | https://www.legemiddelverket.no ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Norwegian Medicines Agency Description of subject: The Norwegian Medicines Agency is Norway’s national regulatory authority responsible for the approval, monitoring, and safe use of medicines and related health products.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Statens legemiddelverk